19 Analysts Have This To Say About Sage Therapeutics
19 Analysts Have This To Say About Sage Therapeutics
19个分析师对sage therapeutics发表了看法
Across the recent three months, 19 analysts have shared their insights on Sage Therapeutics (NASDAQ:SAGE), expressing a variety of opinions spanning from bullish to bearish.
在最近的三个月里，19位分析师分享了他们对Sage Therapeutics（纳斯达克：SAGE）的见解，表达了从看好到看淡各种观点。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级概况，突出了过去30天内情绪的变化，并将其与之前的月份进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for Sage Therapeutics, presenting an average target of $19.63, a high estimate of $29.00, and a low estimate of $8.00. This current average has decreased by 22.32% from the previous average price target of $25.27.
在评估12个月的价格目标时，分析师揭示了Sage Therapeutics的见解，呈现了平均目标为19.63美元，高估为29.00美元，低估为8.00美元。当前平均值比先前的平均价格目标$25.27下降了22.32％。
Decoding Analyst Ratings: A Detailed Look
分析师评级解读：详细解析
The standing of...
通过对...
登录免费看全文
登录/注册